National Comprehensive Cancer Network

Educational Events & Programs

NCCN CME/CE Programs

Earn CME/CE credit with our online, interactive learning center. Access free, continuing education activities.

NCCN CME/CE Programs include presentation webcasts, streaming videos, podcasts, and an audio library of presentations from the NCCN Annual Conference, Annual Congress, and Regional Guidelines in Oncology™ Symposia.

NCCN CME/CE Programs also include JNCCN Task Force Supplements*, for which NCCN convenes experts from within and beyond NCCN Member Institutions to expand on issues discussed in the NCCN Guidelines and to discuss issues outside the scope of the NCCN Guidelines.

NCCN CME/CE Programs are approved for AMA PRA Category 1 Credit™ and are also approved for nursing contact hours. (Note: Streaming videos are not approved for CME/CE credit.)

Acute Myeloid Leukemia

• Epigenetic Modulation in Hematologic Malignancies: Challenges and Progress (Text Article)

Bladder Cancer

• NCCN Task Force Report: Clinical Utility of PET in a Variety of Tumor Types (JNCCN Supplement)

Breast Cancer

• Advances in the Use of Aromatase Inhibitors in the Treatment of Breast Cancer (Webcast | CD-ROM | Podcast/MP3 | Podcast Evaluation)
• Controversies in Cancer Screening (Webcast)
• NCCN Clinical Practice Guidelines in Oncology™ Breast Cancer (Webcast | CD-ROM | Podcast/MP3 | Podcast Evaluation)
• NCCN – MedscapeCME Oncology Breast Cancer Tumor Board (Webcast)
• NCCN Task Force Report: Adjuvant Therapy for Breast Cancer (JNCCN Supplement*)
• NCCN Task Force Report: Breast Cancer in the Older Woman (JNCCN Supplement*)
• NCCN Task Force Report: HER2 Testing in Breast Cancer (JNCCN Supplement*)
• NCCN Task Force Report: Integration of ER/PR Tumor Markers into Treatment Planning for Breast Cancer (Webcast | CD-ROM | Podcast/MP3 | Podcast Evaluation)
• NCCN Task Force Report: mTOR Inhibition in Solid Tumors (JNCCN Supplement*)
• NCCN Task Force Report: PET/CT Scanning in Cancer (JNCCN Supplement*)
• New Advances in Risk Reduction for Recurrence of Breast Cancer in Premenopausal Women (Webcast | CD-ROM | Podcast/MP3 | Podcast Evaluation)
• The Utility of PET/CT Imaging in Oncology (Webcast)

Central Nervous System Cancers

• NCCN Task Force Report: Clinical Utility of PET in a Variety of Tumor Types (JNCCN Supplement)

Cervical Cancer

• NCCN Task Force Report: Clinical Utility of PET in a Variety of Tumor Types (JNCCN Supplement)

Chronic Myelogenous Leukemia

• Epigenetic Modulation in Hematologic Malignancies: Challenges and Progress (Text Article)
• NCCN Task Force Report: Molecular Markers in Leukemia and Lymphoma (Webcast | CD-ROM | Podcast/MP3 | Podcast Evaluation)

Colon/Rectal/Anal Cancers

• NCCN Clinical Practice Guidelines in Oncology™ Colon and Rectal Cancers (Webcast | CD-ROM | Podcast/MP3 | Podcast Evaluation)
• NCCN Colon and Rectal Cancers Guidelines Update (Webcast | CD-ROM | Podcast/MP3 | Podcast Evaluation)
• NCCN – MedscapeCME Oncology Metastatic Colorectal Cancer Tumor Board (Webcast)
• NCCN Task Force Report: PET/CT Scanning in Cancer (JNCCN Supplement*)
• The Utility of PET/CT Imaging in Oncology (Webcast)

Esophageal Cancer

• NCCN Task Force Report: Clinical Utility of PET in a Variety of Tumor Types (JNCCN Supplement)

Gastric Cancer

• NCCN Task Force Report: Clinical Utility of PET in a Variety of Tumor Types (JNCCN Supplement)

Head and Neck Cancers

• NCCN Task Force Report: mTOR Inhibition in Solid Tumors (JNCCN Supplement*)

Healthcare Policy and Practice

• Fostering Multidisciplinary Cancer Care in a Community Setting (Streaming Video)
• Roundtable Discussion – Finding and Achieving Value in Cancer Care (Streaming Video)

Hepatobiliary Cancers

• NCCN Task Force Report: Clinical Utility of PET in a Variety of Tumor Types (JNCCN Supplement)
• NCCN Task Force Report: mTOR Inhibition in Solid Tumors (JNCCN Supplement*)

Kidney Cancer

• NCCN Clinical Practice Guidelines in Oncology™ Kidney Cancer (Webcast | CD-ROM | Podcast/MP3 | Podcast Evaluation)
• NCCN Kidney Cancer Guidelines Update (Webcast | CD-ROM | Podcast/MP3 | Podcast Evaluation)
• NCCN – MedscapeCME Oncology Metastatic Colorectal Cancer Tumor Board (Webcast)
• NCCN Task Force Report: Clinical Utility of PET in a Variety of Tumor Types (JNCCN Supplement)
• NCCN Task Force Report: mTOR Inhibition in Solid Tumors (JNCCN Supplement*)
• Sequencing of Drugs in the Treatment of Kidney Cancer (Webcast | CD-ROM | Podcast/MP3 | Podcast Evaluation)

Multiple Myeloma

• Epigenetic Modulation in Hematologic Malignancies: Challenges and Progress (Text Article)
• NCCN 4^th Annual Congress: Hematologic Malignancies (Webcast)
• NCCN Task Force Report: Clinical Utility of PET in a Variety of Tumor Types (JNCCN Supplement)
• Sequencing Choices in Treatment of Multiple Myeloma (Webcast | CD-ROM | Podcast/MP3 | Podcast Evaluation)

Neuroendocrine Tumors

• NCCN Task Force Report: mTOR Inhibition in Solid Tumors (JNCCN Supplement*)

Non-Hodgkin’s Lymphomas

• Epigenetic Modulation in Hematologic Malignancies: Challenges and Progress (Text Article)
• NCCN 4^th Annual Congress: Hematologic Malignancies (Webcast)
• NCCN Task Force Report: Molecular Markers in Leukemia and Lymphoma (Webcast | CD-ROM | Podcast/MP3 | Podcast Evaluation)
• NCCN Task Force Report: PET/CT Scanning in Cancer (JNCCN Supplement*)

Non-Small Cell Lung Cancer

• 2009 Updates to the NCCN Non-Small Cell Lung Cancer Guidelines (Webcast)
• Controversies in Cancer Screening (Webcast)
• Living with Advanced Non-Small Cell Lung Cancer (Webcast | DVD)
• NCCN Clinical Practice Guidelines in Oncology™ Non-Small Cell Lung Cancer (Webcast | CD-ROM | Podcast/MP3 | Podcast Evaluation)
• NCCN Task Force Report: mTOR Inhibition in Solid Tumors (JNCCN Supplement*)
• NCCN Task Force Report: PET/CT Scanning in Cancer (JNCCN Supplement*)
• New Advances in the First-Line Treatment of Non-Small Cell Lung Cancer (Webcast | CD-ROM | Podcast/MP3 | Podcast Evaluation)
• The Utility of PET/CT Imaging in Oncology (Webcast)

Ovarian Cancer

• Controversies in Cancer Screening (Webcast)
• NCCN Task Force Report: Clinical Utility of PET in a Variety of Tumor Types (JNCCN Supplement)
• NCCN Task Force Report: mTOR Inhibition in Solid Tumors (JNCCN Supplement*)

Pancreatic Adenocarcinoma

• NCCN Task Force Report: Clinical Utility of PET in a Variety of Tumor Types (JNCCN Supplement)

Patient/Physician Communication

• Communicating With Cancer Patients: When the News Is Bad (Streaming Video)

PET/CT Scanning

• NCCN Task Force Report: Clinical Utility of PET in a Variety of Tumor Types (JNCCN Supplement)
• NCCN Task Force Report: PET/CT Scanning in Cancer (JNCCN Supplement*)
• The Utility of PET/CT Imaging in Oncology (Webcast)

Prostate Cancer

• NCCN Task Force Report: Clinical Utility of PET in a Variety of Tumor Types (JNCCN Supplement)
• NCCN Task Force Report: mTOR Inhibition in Solid Tumors (JNCCN Supplement*)
• The Utility of PET/CT Imaging in Oncology (Webcast)

Small Cell Lung Cancer

• NCCN Task Force Report: Clinical Utility of PET in a Variety of Tumor Types (JNCCN Supplement)

Soft Tissue Sarcoma

• NCCN Task Force Report: Clinical Utility of PET in a Variety of Tumor Types (JNCCN Supplement)
• NCCN Task Force Report: Gastrointestinal Stromal Tumors (GIST) (JNCCN Supplement)

Supportive Care

• NCCN 4^th Annual Congress: Hematologic Malignancies (Webcast)
• NCCN Task Force Report: Bone Health in Cancer Care (Webcast | CD-ROM | Podcast/MP3 | Podcast Evaluation)
• NCCN Task Force Report: Management of Dermatologic and Other Toxicities Associated With EGFR Inhibition in Patients With Cancer (Webcast | CD-ROM | Podcast/MP3 | Podcast Evaluation)
• NCCN Task Force Report: Oral Chemotherapy (JNCCN Supplement)
• NCCN Task Force Report: Prevention and Management of Mucositis in Cancer Care (JNCCN Supplement)

Survivorship

• Roundtable Discussion – Cancer as a Chronic Disease: What Should be Done to Serve Cancer Survivors in 2009 and Beyond? (Streaming Video)

Thyroid Carcinoma

• NCCN Task Force Report: Clinical Utility of PET in a Variety of Tumor Types (JNCCN Supplement)
• The Utility of PET/CT Imaging in Oncology (Webcast)

Uterine Neoplasms

• NCCN Task Force Report: Clinical Utility of PET in a Variety of Tumor Types (JNCCN Supplement)
• NCCN Task Force Report: mTOR Inhibition in Solid Tumors (JNCCN Supplement*)

* Please see individual task force report for more information on CME/CE credits.

These files are for individual use only; printing out multiple copies is strictly prohibited. You may not reproduce and/or distribute any file in other formats or media or for any other purposes. For multiple copies/reprints, please contact David Horowitz.

Each JNCCN supplement is copyrighted by the National Comprehensive Cancer Network. All rights reserved. This file may not be used for any other purposes without further permission from the National Comprehensive Cancer Network. Permission can be requested at here.

You are not permitted to translate, reformat, add to, rearrange, delete pages, extract portions, modify, adapt, or change any parts of this file without further permission from the National Comprehensive Cancer Network. You are not permitted to place advertisements or logos of any kind on or within this file. You are not permitted to distribute this file electronically (including via internet, CD-ROM, PDA, DVD, etc...).